TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Volume of blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distant metastases-free survival
Endpoint domain: Mortality/survival
Primary endpoint: positive symptomatic response to PPI treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Asthma control test (ACT) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of initiating cigarette use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ANGPTL3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FMA-M score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FMA-S score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in ambulatory activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieving 150 min/week of moderate-to-vigorous physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted area under the curve (AUC) change in systolic blood pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neutralization titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: wound cosmesis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: vision loss ≥5 letters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Use of gender-specific words in letters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of ability words in letters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mention of honors status in letters
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PROMIS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SF-12 PHS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Relative IHTG loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ratio of B10 cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: FACT-B score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Severity of fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Fatigue
Primary endpoint: Decrease of total BSS from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: standardized math exam scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patients' depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carers’ depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADL and walking ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: PACIC 5A sum score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: readiness for weight management
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: supine AHI (Apnoea-Hypopnoea Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of broken screws
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in GAD-7 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in bonding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of gout
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory deficit
Endpoint domain: Adverse events/effects
Primary endpoint: mental health stability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: health behaviors stability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: AIP as a marker for preeclampsia prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of models
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skeletal muscle O2 conductance (Dm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2 kinetics (mean response time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alveolar capillary membrane O2 conductance (DL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in total E. faecalis count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensory neuropathy prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mortality over 180 days
Endpoint domain: Mortality/survival
Primary endpoint: Risk of acute pancreatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma levels of triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean time differences between follow-ups
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Range of motion interobserver concordance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virtual follow-up satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Low sexual function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of Major Depressive Episode (MDE)
Endpoint domain: Mortality/survival
Primary endpoint: FBG (fasting glucose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adolescent behavioral problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adolescent attachment insecurity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Nutritional quality of grocery purchases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Health risk levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGF‐1 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: strength of the right‐ and left‐hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binge eating score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Symptoms of food addiction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive SP elongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: injectable discontinuation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: First-onset depressive disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evidence of disease
Endpoint domain: Mortality/survival
Primary endpoint: Urinary control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: changes in knowledge, attitude and practice of nutrition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Probability of having a restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Probability of sealant loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Re-application rate of sealants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Relative bioavailability of MR paracetamol compared to IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of making different toxicity assessments
Endpoint domain: Adverse events/effects
Primary endpoint: clinical remission at Week 26
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sustained remission at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with educational methods
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to UC recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with virtual simulation-based training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Completion of training program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ACQ‐7
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decreases in heavy drinking days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increases in percentage of days abstinent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decreases in overall psychological distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: post-operative RIFLE-defined AKI rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 6-h post-CPB plasma NGAL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Operating room time (ORT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: incidence rate of overall infectious morbidities
Endpoint domain: Adverse events/effects
Primary endpoint: Response to acupuncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preferred delivery
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: improvement in hemispatial neglect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in motivation and self-efficacy scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patellar tendon load response (LR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: HF readmission
Endpoint domain: Mortality/survival
Primary endpoint: ELF concentration of IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevention of PSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cost-effectiveness (QALYs)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Nadolol AUC0-48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: participation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: FEV1 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PEFR scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PALS performance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of puffs consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fractional exhaled nitric oxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Overall impact on QoL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total ICIQ-LUTSqol scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: risk of any intracerebral hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in the number of residual pockets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular strain (heart rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: vascular access-related severe complication rates
Endpoint domain: Adverse events/effects
Primary endpoint: Interchangeability of venous and capillary sodium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Post-vibration sustained torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Torque during vibration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Involuntary torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: end of all indicated diagnostic work-up time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: end of neurological examination time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: end of computed tomography time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lowering of plasma Lp(a) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Colony-forming units/ml count of bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: PAVM reperfusion rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: periprocedural complication rates
Endpoint domain: Adverse events/effects
Primary endpoint: contrast volume utilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of bleeding (Bleeding Academic Research Consortium types 2-5)
Endpoint domain: Adverse events/effects
Primary endpoint: normal mean urinary free cortisol (mUFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 12-month patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: phlebotomy success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in infusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: port site pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exacerbation-free rate
Endpoint domain: Adverse events/effects
Primary endpoint: Median time to epinephrine administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MOT speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommendation rate by parents
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: mRS score less than 3 (good outcome)
Endpoint domain: Mortality/survival
Primary endpoint: mean hospital stay duration
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Reducing post-traumatic stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enhancing quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Urinary NO3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static two-point discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AB to smoking and alcohol cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SCP delivery adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: rehabilitation milestones
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distance of ambulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incorrect renal puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: reduction of distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lumbar spine functionality improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of melasma (mMASI score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood-related markers of muscle soreness (creatine kinase, LDH, myoglobin, MDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to home intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Physical health component (PCS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mental health component (MCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bodily pain (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inappropriate gestational weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experience of antenatal care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bone resorption marker (CTX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-reported new employment status
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: Retention in the program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intimate partner violence indicators
Endpoint domain: Adverse events/effects
Primary endpoint: Calories ordered for children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calories ordered for parents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycated hemoglobin (HbA1c) changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulin AUC0–120 min levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Success rate of primary and secondary reduction
Endpoint domain: Mortality/survival
Primary endpoint: VAS scores after reduction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: error in estimating the optimal bolus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of in-person visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Personal costs related to follow-up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Health care system costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: amount consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protective levels of RVNA (≥0.5 IU/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Benefit Rate (PR + SD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in bladder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of urinary incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure freedom for ≥1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Bodily pain score (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ellipse area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mediolateral/anteroposterior root‐mean‐square
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of transfer errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication Related Problems (MRPs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in E. faecalis colony count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Influenza vaccine effectiveness (VE) against acute chest syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hair regrowth percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Frailty scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Correct application of tourniquet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of wounds warranting a tourniquet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported willingness and comfort in using tourniquets
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean annual cost per participant
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PASI score percent improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cathelicidin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for diagnosing clinically intact repairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity for diagnosing clinically failed repairs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SER (Spherical Equivalent Refraction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in AL (Axial Length)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MPP-deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of new significant AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Sprint capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes